Thinking of switching? How to change your Mounjaro supplier safely

Picture the moment you decide to switch

You have been on Mounjaro for a couple of months and something has prompted a change: delivery times, a price difference you spotted while reading a Mounjaro price comparison, a friend's recommendation, or simply wanting a service with more clinical support. The good news is that switching is straightforward in principle. The important word is "in principle".

Mounjaro is a prescription-only medicine, regulated under the Human Medicines Regulations 2012. That status does not change when you change supplier. The new pharmacy cannot simply take over where the old one left off by logging your name into a system. A GPhC-registered prescriber at the new service has to assess you afresh (reviewing your health, your current dose, your tolerability so far) and issue their own prescription. That is not a bureaucratic obstacle; it is the thing that keeps you safe.

A question our prescribers hear most weeks is whether a patient can just bring their current dose and carry straight on. They can, provided they can show the new prescriber where they are in treatment. Evidence of your dose history (a letter, a previous prescription, a dispensing record) makes the process faster and means the clinical review is properly informed rather than guesswork.

If there has been a gap in treatment (even a week or two) your new prescriber needs to know. Breaks can change how your body responds on restarting, and a prescriber who does not ask about gaps is a prescriber not giving your safety the attention it deserves.

What a responsible supplier will ask before continuing your dose

Switching to a higher dose than 2.5 mg without evidence of your previous treatment is one of the clearest red flags in the private weight-loss space. The criteria that distinguish a quality Mounjaro supplier from a permissive one include exactly this: whether the prescriber asks for proof before continuing or escalating a dose.

At nume (sorry, at a regulated service) the prescriber at the point of transfer will typically want to see documentation of your current dose and how long you have been on it. Dose increases should be supported by evidence of tolerance and progress, not just your say-so. This is not distrust; it is the clinical standard that applies whether you are joining a service for the first time or moving across from another provider.

The GPhC-registered prescriber also needs to assess whether Mounjaro remains appropriate for you now. Circumstances change. A condition that was stable at your first consultation may have evolved. New medicines may have been added. A responsible transfer consultation covers all of this, not just "which dose do you want?"

It is also worth checking what aftercare looks like at the new supplier. Some services focus on the initial prescription and offer little support between orders. For a medicine where side-effect management and dose adjustment matter, ongoing access to clinical advice (not just a chatbot) is worth weighing alongside price. You can read more about how UK Mounjaro suppliers differ in their approach to ongoing care.

Verifying the new supplier before you commit

The MHRA has warned repeatedly about fake weight-loss pens sold online and via social media, and enforcement operations in 2025 resulted in the seizure of around 20 million doses of illegally traded weight-loss medicines (approximately £45 million in street value), including counterfeit tirzepatide pens traced to an unlicensed manufacturing site. When you change supplier, you are choosing a new entry point into the supply chain.

The two-minute check is straightforward: look up the pharmacy on the GPhC pharmacy register. Every legitimate UK online pharmacy has a premises registration number that appears on that register. If a supplier cannot be found there, do not hand over payment details or, more importantly, your health. Red flags include prices far below market, no consultation step, and sellers operating via social media rather than a regulated website.

At nume, our GPhC premises registration number is 9012878, verifiable directly on the register. Medicines are sourced through the licensed UK supply chain with authorised supplier relationships. We mention this not to promote ourselves but because every supplier you consider should be able to say the same. For broader context on what to look for in a UK provider, the tirzepatide supplier guide covers the key questions in detail.

If you want to explore your supply options more broadly, the NHS advice on tirzepatide sets out what clinical oversight of the medicine looks like, which is a useful benchmark for judging any supplier's process.

The practical steps when you are ready to switch

Once you have identified a GPhC-registered pharmacy you trust, the process is usually: complete a consultation (clinical, not a checkbox exercise), supply your dose history and any relevant medical information, complete identity and weight verification, and receive a new prescription if the prescriber considers the treatment appropriate for you. You do not need a referral letter from your previous supplier, though having your dose records to hand speeds things up.

Timing matters if you are mid-cycle. Ideally, switch at the point where you would naturally place a repeat order, so there is no gap in treatment. If a gap is unavoidable, be upfront about it in the new consultation. Your prescriber can factor it in. You can find more about Mounjaro and how treatment works on our Mounjaro overview page, or explore other tirzepatide topics through our tirzepatide information hub. If supply availability near you is a factor in your decision, the guide to finding Mounjaro suppliers is worth a read before you decide.

If you are ready to start a fresh consultation with a service that reviews every transfer clinically and dispatches the same day once approved, speak to our prescribers, it takes a few minutes to begin.